Tisento Therapeutics
PrivateLast Round
Series A
Jul 28, 2023
Est. Valuation
$100M
Total Funding Raised
$81M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tisento Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in July 2023.
Tisento Therapeutics is a biotechnology company developing novel medicines for the treatment of rare mitochondrial diseases, including Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes (MELAS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tisento Therapeutics Comparables
Compare Tisento Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharming Group N.V. | 85% | |
| Khondrion | 84% | |
| Cyclerion Therapeutics | 80% |
For institutional investors. Book with your work email.
Tisento Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tisento Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invus Opportunities | Series A |
| Sanofi Ventures | Series A |
| J. Wood Capital Advisors | Series A |
| Venrock | Series A |
| Polaris Partners | Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 72% MoM, reaching 2.9K.
- May 17, 2026
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
Tisento Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tisento Therapeutics's valuation, stock price, and market status.
Is Tisento Therapeutics a public or private company?
Tisento Therapeutics is a private company.
What is the current stock price of Tisento Therapeutics?
Tisento Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tisento Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tisento Therapeutics worth (valuation)?
Tisento Therapeutics's valuation is estimated at $100.0M based on funding round data.
Can I buy Tisento Therapeutics stock?
Tisento Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tisento Therapeutics's last funding round?
Tisento Therapeutics's most recent funding round was Series A on July 28, 2023.
Who are the main investors in Tisento Therapeutics?
Key investors in Tisento Therapeutics include Invus Opportunities, Sanofi Ventures, J. Wood Capital Advisors, Venrock.
Will Tisento Therapeutics IPO soon?
No public IPO plans have been announced for Tisento Therapeutics.
How can I track Tisento Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tisento Therapeutics's shares on secondary markets.